New Zealand markets open in 8 hours 28 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
353.03-4.27 (-1.20%)
At close: 04:00PM EDT
353.00 -0.03 (-0.01%)
Pre-market: 08:01AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.37B
Enterprise value 10.03B
Trailing P/E N/A
Forward P/E 24.45
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)3.77
Price/book (mrq)1.22
Enterprise value/revenue 3.62
Enterprise value/EBITDA -29.29

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-14.83%
S&P500 52-week change 318.19%
52-week high 3509.62
52-week low 3344.63
50-day moving average 3388.79
200-day moving average 3421.25

Share statistics

Avg vol (3-month) 3189.03k
Avg vol (10-day) 3187.45k
Shares outstanding 524M
Implied shares outstanding 629.31M
Float 820.54M
% held by insiders 114.51%
% held by institutions 180.74%
Shares short (30 Aug 2023) 4435.05k
Short ratio (30 Aug 2023) 42.59
Short % of float (30 Aug 2023) 42.09%
Short % of shares outstanding (30 Aug 2023) 41.50%
Shares short (prior month 30 Jul 2023) 4336.25k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -15.47%
Operating margin (ttm)14.22%

Management effectiveness

Return on assets (ttm)2.00%
Return on equity (ttm)-4.93%

Income statement

Revenue (ttm)2.77B
Revenue per share (ttm)93.58
Quarterly revenue growth (yoy)-1.40%
Gross profit (ttm)1.57B
EBITDA 534.95M
Net income avi to common (ttm)-428.36M
Diluted EPS (ttm)-14.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.72B
Total cash per share (mrq)59.25
Total debt (mrq)1.38B
Total debt/equity (mrq)16.36%
Current ratio (mrq)5.39
Book value per share (mrq)290.51

Cash flow statement

Operating cash flow (ttm)286.82M
Levered free cash flow (ttm)159.37M